These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 14578322

  • 1. Sensitive HPLC-fluorescence method for irinotecan and four major metabolites in human plasma and saliva: application to pharmacokinetic studies.
    Poujol S, Pinguet F, Malosse F, Astre C, Ychou M, Culine S, Bressolle F.
    Clin Chem; 2003 Nov; 49(11):1900-8. PubMed ID: 14578322
    [Abstract] [Full Text] [Related]

  • 2. Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
    de Bruijn P, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A.
    J Chromatogr B Biomed Sci Appl; 1997 Sep 26; 698(1-2):277-85. PubMed ID: 9367218
    [Abstract] [Full Text] [Related]

  • 3. High-performance liquid chromatographic assay with fluorescence detection for the simultaneous measurement of carboxylate and lactone forms of irinotecan and three metabolites in human plasma.
    Owens TS, Dodds H, Fricke K, Hanna SK, Crews KR.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May 05; 788(1):65-74. PubMed ID: 12668072
    [Abstract] [Full Text] [Related]

  • 4. Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma.
    Rivory LP, Robert J.
    J Chromatogr B Biomed Appl; 1994 Nov 04; 661(1):133-41. PubMed ID: 7866541
    [Abstract] [Full Text] [Related]

  • 5. Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and feces.
    Sparreboom A, de Bruijn P, de Jonge MJ, Loos WJ, Stoter G, Verweij J, Nooter K.
    J Chromatogr B Biomed Sci Appl; 1998 Aug 07; 712(1-2):225-35. PubMed ID: 9698245
    [Abstract] [Full Text] [Related]

  • 6. Clinical pharmacokinetics of irinotecan and its metabolites: a population analysis.
    Xie R, Mathijssen RH, Sparreboom A, Verweij J, Karlsson MO.
    J Clin Oncol; 2002 Aug 01; 20(15):3293-301. PubMed ID: 12149304
    [Abstract] [Full Text] [Related]

  • 7. A liquid chromatography/electrospray ionization mass spectrometry (LC-MS/MS) assay for the determination of irinotecan (CPT-11) and its two major metabolites in human liver microsomal incubations and human plasma samples.
    D'Esposito F, Tattam BN, Ramzan I, Murray M.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov 15; 875(2):522-30. PubMed ID: 18952506
    [Abstract] [Full Text] [Related]

  • 8. An analytical method for irinotecan (CPT-11) and its metabolites using a high-performance liquid chromatography: parallel detection with fluorescence and mass spectrometry.
    Sai K, Kaniwa N, Ozawa S, Sawada J.
    Biomed Chromatogr; 2002 May 15; 16(3):209-18. PubMed ID: 11920947
    [Abstract] [Full Text] [Related]

  • 9. Determination by liquid chromatography with fluorescence detection of total 7-ethyl-10-hydroxy-camptothecin (SN-38) in beagle dog plasma after intravenous administration of liposome-based SN-38 (LE-SN38).
    Guo W, Ahmad A, Khan S, Dahhani F, Wang YF, Ahmad I.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul 05; 791(1-2):85-92. PubMed ID: 12798168
    [Abstract] [Full Text] [Related]

  • 10. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography.
    Park DJ, Won JH, Cho AR, Yun HJ, Heo JH, Hwhang TH, Lee DH, Kim WM.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul 01; 962():147-152. PubMed ID: 24927278
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients.
    Barilero I, Gandia D, Armand JP, Mathieu-Boué A, Ré M, Gouyette A, Chabot GG.
    J Chromatogr; 1992 Mar 27; 575(2):275-80. PubMed ID: 1629304
    [Abstract] [Full Text] [Related]

  • 12. High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-phase extraction system, PROSPEKT.
    Kurita A, Kaneda N.
    J Chromatogr B Biomed Sci Appl; 1999 Mar 19; 724(2):335-44. PubMed ID: 10219676
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat.
    Yang X, Hu Z, Chan SY, Goh BC, Duan W, Chan E, Zhou S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul 25; 821(2):221-8. PubMed ID: 15936253
    [Abstract] [Full Text] [Related]

  • 14. High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma.
    Schoemaker NE, Rosing H, Jansen S, Schellens JH, Beijnen JH.
    Ther Drug Monit; 2003 Feb 25; 25(1):120-4. PubMed ID: 12548157
    [Abstract] [Full Text] [Related]

  • 15. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
    Atasilp C, Chansriwong P, Sirachainan E, Reungwetwattana T, Puangpetch A, Prommas S, Sirilerttrakul S, Rerkarmnuaychoke B, Wongwaisayawan S, Sukasem C.
    J Clin Lab Anal; 2018 Jan 25; 32(1):. PubMed ID: 28393405
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.
    Rivory LP, Haaz MC, Canal P, Lokiec F, Armand JP, Robert J.
    Clin Cancer Res; 1997 Aug 25; 3(8):1261-6. PubMed ID: 9815808
    [Abstract] [Full Text] [Related]

  • 17. Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies.
    Escoriaza J, Aldaz A, Castellanos C, Calvo E, Giráldez J.
    J Chromatogr B Biomed Sci Appl; 2000 Apr 14; 740(2):159-68. PubMed ID: 10821401
    [Abstract] [Full Text] [Related]

  • 18. High-performance liquid chromatographic determination of irinotecan (CPT-11) and its active metabolite (SN-38) in human plasma.
    Sumiyoshi H, Fujiwara Y, Ohune T, Yamaoka N, Tamura K, Yamakido M.
    J Chromatogr B Biomed Appl; 1995 Aug 18; 670(2):309-16. PubMed ID: 8548021
    [Abstract] [Full Text] [Related]

  • 19. Identification and kinetics of a beta-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan.
    Rivory LP, Robert J.
    Cancer Chemother Pharmacol; 1995 Aug 18; 36(2):176-9. PubMed ID: 7767955
    [Abstract] [Full Text] [Related]

  • 20. Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatography.
    de Bruijn P, de Jonge MJ, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A.
    Anal Biochem; 1999 Apr 10; 269(1):174-8. PubMed ID: 10094790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.